A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...
Posterial Cortical Atrophy, sometimes called Benson’s disease, is a rare degenerative brain condition that affects the back ...
In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...
A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...
A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...
MADISON, Wis.- A groundbreaking national study into the causes of Alzheimer’s and dementia has begun, led by researchers at ...
As our family members age, we worry. We worry about their physical health and potential cognitive declines. If you are ...
In the second hour of "Connections with Evan Dawson" on Oct. 22, 2024, our guests discuss caregiving for people with ...
Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...
Bilingualism has long been known to have cognitive benefits for older adults. Research shows it helps delay the onset of ...